Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery
- Conditions
- Prostate Cancer
- Interventions
- Procedure: ultrasound imagingProcedure: robot-assisted laparoscopic surgery
- Registration Number
- NCT01495130
- Lead Sponsor
- University of Southern California
- Brief Summary
This pilot clinical trial studies mechanically-manipulated ultrasound in finding tumors during robotic-assisted surgery in patients with prostate cancer. Diagnostic procedures, such as ultrasound, may help find prostate cancer and find out how far the disease has spread during surgery
- Detailed Description
PRIMARY OBJECTIVES: I. To assess the feasibility and limitations of using a mechanically-manipulated transrectal ultrasound (TRUS) probe for TRUS evaluation during a da Vinci robotic-assisted laparoscopic prostatectomy (RALP). II. To collect TRUS evaluation data during RALP to guide us in deciding whether and how the mechanical manipulation of the TRUS probe will allow sufficient clarity of ultrasound imaging. OUTLINE: Patients undergo TRUS during RALP. After the completion of study treatment, patients are followed up at 7 days.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 11
- Undergoing Robotic Assisted Laparoscopic Prostatectomy
- Known or discovered rectal pathology
- Bleeding hemorrhoids
- Rectal stenosis
- Any prior rectal surgeries
- Prior rectal radiation
- Any known rectal disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Diagnostic (TRUS) ultrasound imaging Patients undergo TRUS during RALP. Diagnostic (TRUS) robot-assisted laparoscopic surgery Patients undergo TRUS during RALP.
- Primary Outcome Measures
Name Time Method Number of patients who have negative margins when a TRUS probe is used during RALP procedure without introducing additional complications. 7 days post-RALP
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
USC/Norris Comprehensive Cancer Center
🇺🇸Los Angeles, California, United States